To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Abarceo Pharma has identified a novel diabetes target located on beta cells and a novel mechanism of action enabling a therapeutic treatment to revert beta cells from dysfunctional to functional, preserving beta cell function and allowing patients to produce their own insulin again, naturally.
- 1Intas Biopharmaceuticals Ltd.
- 2Ranbaxy Laboratories Ltd.
- 3Life Technologies Corporation
- 4Autobio Diagnostics Co., Ltd
- 5BIOTON S.A.
- 6Sanofi-Aventis Deutschland GmbH
- 7Abbott GmbH & Co. KG
- 8Scientis Pharma SA
- 9LPT - Laboratory of Pharmacology and Toxicology GmbH & Co. KG
- 10MEDICE Arzneimittel Pütter GmbH & Co. KG